Live Breaking News & Updates on Precisa Medicamentos

Stay updated with breaking news from Precisa medicamentos. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

COVID: 50 million Covaxin doses set to expire early 2023 due to poor off take

Covaxin news: In April this year, the World health Organization said it confirmed the suspension of supply of Covaxin through UN procurement agencies and recommended that countries using the vaccine take action as appropriate. ....

Precisa Medicamentos , Envixia Pharmaceuticals , World Health Organization , Central Drugs Standard Control Organisation , Google News , Image Source , Bharat Biotech , Covaxin News , Covaxin Booster Dose , Covaxin Dose , Ovid Covaxin Dose , Covaxin Side Effects , Covaxin Efficacy , Ovaxin Latest News Today , Ovaxin News Updates ,

50 mn doses of Covaxin set to expire early 2023 due to poor off take - Jammu Kashmir Latest News | Tourism

NEW DELHI, Nov 6: Nearly 50 million doses of Bharat Biotech’s COVID-19 vaccine, Covaxin lying with the firm are set to expire early next year as there are no takers owing to poor demand, company sources said. Due to lack of product demand, production stoppage of Covaxin – a two dose jab, was initiated by Bharat Biotech earlier this year, though the vaccine maker has established manufacturing to reach an annualised capacity of 1 billion doses at the end of […] ....

Precisa Medicamentos , Envixia Pharmaceuticals , Central Drugs Standard Control Organisation , Bharat Biotech ,

Almost 50 mn doses of Indian vaccine Covaxin to be wasted due to poor demand

So far, 219.71 crore doses of COVID-19 vaccines, including Covaxin have been administered under the nationwide vaccination drive. ....

Precisa Medicamentos , Envixia Pharmaceuticals , Central Drugs Standard Control Organisation , Bharat Biotech ,

50 Million Doses Of Covaxin Set To Expire Early 2023: Report

Nearly 50 million doses of Bharat Biotech's COVID-19 vaccine, Covaxin lying with the firm are set to expire early next year as there are no takers owing to poor demand, company sources said. ....

Precisa Medicamentos , Envixia Pharmaceuticals , Central Drugs Standard Control Organisation , Bharat Biotech , Video Of The ,